supply of - e cfa re 39 inj ciprofloxacin 200mg 100ml bott of 100ml , e cfa re 39 inj dexamethasone sodium phosphate 4 dot 4 mg equivalent to dexamethasone phosphate 4 mg ml 2 ml , e cfa re 39 glucose solution 5 in non-toxic disposable plastic bott of 500ml ffs , e cfa re 39 inj dextrose 25 25 ml , e cfa re 39 inj dextrose 50 25 ml , e cfa re 39 inj erythropoietin recombinant human 2000 iu , e cfa re 39 haloperidol 5mg ml inj , e cfa re 39 inj hepatitis b vaccin 10ml , e cfa re 39 inj human insu

Indian Army has invited bids for the supply of - e cfa re 39 inj ciprofloxacin 200mg 100ml bott of 100ml , e cfa re 39 inj dexamethasone sodium phosphate 4 dot 4 mg equivalent to dexamethasone phosphate 4 mg ml 2 ml , e cfa re 39 glucose solution 5 in non-toxic disposable plastic bott of 500ml ffs , e cfa re 39 inj dextrose 25 25 ml , e cfa re 39 inj dextrose 50 25 ml , e cfa re 39 inj erythropoietin recombinant human 2000 iu , e cfa re 39 haloperidol 5mg ml inj , e cfa re 39 inj hepatitis b vaccin 10ml , e cfa re 39 inj human insulin glargine 300iu ml 3ml cartridge , e cfa re 39 ferric hydroxide sucrose complex 20 mg in 5ml for injection iron sucrose , e cfa re 39 levofloxacin 500 mg in 100 ml inj , e cfa re 39 lignocaine hcl 2 with adrenaline 1 80000 30 ml inj , e cfa re 39 inj mannitol 20 bott of 100 ml , e cfa re 39 inj methylcobalamin 1000mcg vitamin b6 pyridoxine 100mg , e cfa re 39 inj methylcobalamin 1500 mcg ml ampoule of 1ml , e cfa re 39 metronidazole inj for iv use containing 500 mg per bott of 100 ml , e cfa re 39 inj nitroglycerin 5mg , e cfa re 39 sodium chloride isotonic solution 100 ml self collapsible container ffs , e cfa re 39 ondansetron 2mg ml 4 ml inj , e cfa re 39 noradrenaline bitartrate 2 mg ml 2 ml inj , e cfa re 39 triamcinalone acetate 40mg ml inj kenakort vial of 1ml , e cfa re 39 amiodarone hcl 150 mg 3ml inj , e cfa re 39 ofloxacin syp 0 dot 3 bott of 5ml , e cfa re 39 syp metronidazole 60ml , e cfa re 39 syp mucaine gel oxetacaine 10mg 5ml aluminium hydroxide 0 dot 291gm 5ml , e cfa re 39 acyclovir ophth ointment 3 w w in 5gm tube , e cfa re 39 lidocaine 4 w w metronidazole 1 w w sucralfate 7 , e cfa re 39 liq paraffin 100ml bott , e cfa re 39 metronidazole 1 chlorhexidine 1 lignocaine 2 oral gel tube of 15g , e cfa re 39 minoxidil 10 solution bott of 50 60ml , e cfa re 39 mometasone 0 dot 5 tube of 10 gm oint , e cfa re 39 neomycin 3400iu polymyxin 5000iu bacitracin 400iu neosporin oint tube of 10gm , e cfa re 39 oin clobetasol salicylic acid dipsalic , e cfa re 39 oint beclomethasone salicylic acid , e cfa re 39 oint clobetasole 0 dot 05 salicylic acid 3 dot 5 propylene glycol oint tube of 20gm , e cfa re 39 lotion povidone-iodine germicidal gargle 2 w v bott of 100ml betadine , e cfa re 39 salicylic acid coal tar oint protar , e cfa re 39 silver nitrate chlorhexidine oint burnheal , e cfa re 39 silver sulfadiazine oint 1 w w tube of 10gm , e cfa re 39 tretinoin 0 dot 05 oint tube of 30gm , e cfa re 39 betamethasone 0 dot 1 neomycin 0 dot 5 oint tube of 25 gm , e cfa re 39 candid mouth paint clotrimazole , e cfa re 39 choline salicylate 8 dot 7 lidocaine 2 dologel , e cfa re 39 clindamycin 1 adapalene 0 dot 1 aloe allantoin gel tube of 15 gm , e cfa re 39 clindamycin 1 gel 10 gm , e cfa re 39 clobetasol miconozole gentamycin oint , e cfa re 39 forglyn formoterol 6mcg glycopyrrolate 25mcg respicaps , e cfa re 39 inh formoterol 6 mcg tiotropium 9mcg mdi duova , e cfa re 39 mometasone nasal spray , e cfa re 39 levosalbutamol sulphate 2 dot 5 ml containing 1 dot 25 mg respule , e cfa re 39 budesonide 1mg respules , e cfa re 39 sodium hyaluronate 0 dot 1 eye drops e d , e cfa re 39 eye oint moxifloxacin 0 dot 5 5 gm , e cfa re 39 brimonidine 0 dot 2 timolol 0 dot 5 eye drops bott of 5 ml - drug and pharmaceutical items | quantity - 10138. The estimated project cost is ₹0.01 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 5 October 2026, with the technical opening scheduled for 5 October 2026.